These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1). Zhang L; Xu W Expert Opin Ther Pat; 2015 Feb; 25(2):237-40. PubMed ID: 25381141 [TBL] [Abstract][Full Text] [Related]
23. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method. Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455 [TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole. Bezerra CF; de Alencar Júnior JG; de Lima Honorato R; Dos Santos ATL; Pereira da Silva JC; Gusmão da Silva T; Leal ALAB; Rocha JE; de Freitas TS; Tavares Vieira TA; Bezerra MCF; Sales DL; Kerntopf MR; de Araujo Delmondes G; Filho JMB; Peixoto LR; Pinheiro AP; Ribeiro-Filho J; Coutinho HDM; Morais-Braga MFB; Gonçalves da Silva T Chem Phys Lipids; 2020 Nov; 233():104987. PubMed ID: 33058818 [TBL] [Abstract][Full Text] [Related]
25. Improved yeast delivery of fluconazole with a nanostructured lipid carrier system. Kelidari HR; Moazeni M; Babaei R; Saeedi M; Akbari J; Parkoohi PI; Nabili M; Gohar AA; Morteza-Semnani K; Nokhodchi A Biomed Pharmacother; 2017 May; 89():83-88. PubMed ID: 28222399 [TBL] [Abstract][Full Text] [Related]
26. Fungicidal amounts of antifungals are released from impregnated denture lining material for up to 28 days. Salim N; Moore C; Silikas N; Satterthwaite JD; Rautemaa R J Dent; 2012 Jun; 40(6):506-12. PubMed ID: 22390981 [TBL] [Abstract][Full Text] [Related]
27. Analysis of fluconazole effect on Candida albicans viability during extended incubations. Sohnle PG; Hahn BL; Fassel TA; Kushnaryov VM Med Mycol; 1998 Feb; 36(1):29-36. PubMed ID: 9776809 [TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of antifungal activity of melaleuca oil and fluconazole when incorporated in tissue conditioner: an in vitro study. Sharma S; Hegde V J Prosthodont; 2014 Jul; 23(5):367-73. PubMed ID: 24393097 [TBL] [Abstract][Full Text] [Related]
29. Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier. Radwan IT; El-Sherbiny IM; Metwally NH Sci Rep; 2024 Jun; 14(1):14382. PubMed ID: 38909063 [TBL] [Abstract][Full Text] [Related]
30. Antifungal effect of the liposome encapsulation of the Trans- Caryophylene and its association with fluconazole. Bezerra CF; Geraldo de Alencar Júnior J; de Lima Honorato R; Lucas Dos Santos AT; Pereira da Silva JC; Gusmão da Silva T; Sampaio de Freitas T; Fonseca Bezerra MC; Alves Borges Leal AL; Sales DL; Viana Rodrigues JP; Barbosa Filho JM; Peixoto LR; Pinheiro AP; Melo Coutinho HD; Bezerra Morais-Braga MF; Gonçalves da Silva T Chem Biol Interact; 2023 Mar; 373():110377. PubMed ID: 36754224 [TBL] [Abstract][Full Text] [Related]
31. Effect of fluconazole on viability of Candida albicans over extended periods of time. Sohnle PG; Hahn BL; Erdmann MD Antimicrob Agents Chemother; 1996 Nov; 40(11):2622-5. PubMed ID: 8913476 [TBL] [Abstract][Full Text] [Related]
32. Study of the elution of fluconazole from a self-polymerizing acrylic resin and its activity against resistant Candida albicans. Darwish RM; Amin WM; Al-Ali MH; Salem NA J Mater Sci Mater Med; 2011 Aug; 22(8):1885-90. PubMed ID: 19844777 [TBL] [Abstract][Full Text] [Related]
33. Fluconazole release from hydrogels including acrylamide-acrylic acid-itaconic acid, and their microbiological interactions. Pulat M; Eksi H; Abbasoglu U J Biomater Sci Polym Ed; 2008; 19(2):193-205. PubMed ID: 18237492 [TBL] [Abstract][Full Text] [Related]
34. Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations. De Logu A; Fadda AM; Anchisi C; Maccioni AM; Sinico C; Schivo ML; Alhaique F J Antimicrob Chemother; 1997 Dec; 40(6):889-93. PubMed ID: 9462444 [TBL] [Abstract][Full Text] [Related]
35. Increased in vitro sensitivity of Candida albicans to fluconazole. Simonetti N; D'Auria FD; Strippoli V Chemotherapy; 1991; 37(1):32-7. PubMed ID: 1707357 [TBL] [Abstract][Full Text] [Related]
36. Antifungal Properties of Nerolidol-Containing Liposomes in Association with Fluconazole. Fonseca Bezerra C; de Alencar Júnior JG; de Lima Honorato R; Dos Santos ATL; Pereira da Silva JC; Silva TGD; Leal ALAB; de Freitas TS; Vieira TAT; Esmeraldo Rocha J; Lima Sales D; Barbosa Filho JM; Ribeiro de Sousa G; Pinheiro AP; Ribeiro-Filho J; Coutinho HDM; Bezerra Morais-Braga MF; da Silva TG Membranes (Basel); 2020 Aug; 10(9):. PubMed ID: 32825411 [TBL] [Abstract][Full Text] [Related]
37. HMDSO-plasma coated electrospun fibers of poly(cyclodextrin)s for antifungal dressings. Costoya A; Ballarin FM; Llovo J; Concheiro A; Abraham GA; Alvarez-Lorenzo C Int J Pharm; 2016 Nov; 513(1-2):518-527. PubMed ID: 27667755 [TBL] [Abstract][Full Text] [Related]
38. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. Mehta RT; McQueen TJ; Keyhani A; Lopez-Berestein G J Infect Dis; 1991 Nov; 164(5):1003-6. PubMed ID: 1940451 [TBL] [Abstract][Full Text] [Related]
39. Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin. Egbaria K; Ramachandran C; Weiner N Skin Pharmacol; 1991; 4(1):21-8. PubMed ID: 2064787 [TBL] [Abstract][Full Text] [Related]
40. Characterisation and in vitro antimicrobial potential of liposome encapsulated silver ions against Candida albicans. Low WL; Kenward MA; Hill DJ; Martin C J Microencapsul; 2016; 33(2):146-52. PubMed ID: 26786597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]